Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
Nature Communications
|
November 14, 2017
Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
Manisha Singh, Christina Vianden, Mark J Cantwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 25, 2021
Opening of the Blood-Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models
Aria Sabbagh, Kevin Beccaria, Xiaoyang Ling, et al.
Journal for Immunotherapy of Cancer
|
February 23, 2022
ISA101 and nivolumab for HPV-16<sup>+</sup> cancer: updated clinical efficacy and immune correlates of response
Luana Guimaraes de Sousa, Kimal Rajapakshe, Jaime Rodriguez Canales, et al.
Cancer Immunology Research
|
September 12, 2020
Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype
Ashvin R Jaiswal, Arthur J Liu, Shivanand Pudakalakatti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2016
Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells
Chad Tang, James W Welsh, Patricia de Groot, et al.
Oncology
|
October 20, 2024
Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma
Michael LaPelusa, Shadi Chamseddine, Hop Sanderson Tran Cao, et al.
Journal of Immunotherapy and Precision Oncology
|
February 17, 2025
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial
Mirella Nardo, Mohamed A Gouda, Matthew J Reilley, et al.
The Journal of Clinical Investigation
|
February 16, 2026
STING-induced blood-brain barrier opening combined with radiotherapy potentiates antitumor response in a high-grade glioma model
Shashwat Tripathi, Hinda Najem, Lisa Hurley, et al.
JCI Insight
|
July 30, 2020
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration
Martina Ott, Karl-Heinz Tomaszowski, Anantha Marisetty, et al.
BMJ Oncology
|
January 31, 2025
Preclinical study and parallel phase II trial evaluating antisense STAT3 oligonucleotide and checkpoint blockade for advanced pancreatic, non-small cell lung cancer and mismatch repair-deficient colorectal cancer
Chad Tang, Genevieve P Hartley, Coline Couillault, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
Nature Communications
|
November 14, 2017
Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
Manisha Singh, Christina Vianden, Mark J Cantwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 25, 2021
Opening of the Blood-Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models
Aria Sabbagh, Kevin Beccaria, Xiaoyang Ling, et al.
Journal for Immunotherapy of Cancer
|
February 23, 2022
ISA101 and nivolumab for HPV-16<sup>+</sup> cancer: updated clinical efficacy and immune correlates of response
Luana Guimaraes de Sousa, Kimal Rajapakshe, Jaime Rodriguez Canales, et al.
Cancer Immunology Research
|
September 12, 2020
Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype
Ashvin R Jaiswal, Arthur J Liu, Shivanand Pudakalakatti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2016
Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells
Chad Tang, James W Welsh, Patricia de Groot, et al.
Oncology
|
October 20, 2024
Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma
Michael LaPelusa, Shadi Chamseddine, Hop Sanderson Tran Cao, et al.
Journal of Immunotherapy and Precision Oncology
|
February 17, 2025
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial
Mirella Nardo, Mohamed A Gouda, Matthew J Reilley, et al.
The Journal of Clinical Investigation
|
February 16, 2026
STING-induced blood-brain barrier opening combined with radiotherapy potentiates antitumor response in a high-grade glioma model
Shashwat Tripathi, Hinda Najem, Lisa Hurley, et al.
JCI Insight
|
July 30, 2020
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration
Martina Ott, Karl-Heinz Tomaszowski, Anantha Marisetty, et al.
BMJ Oncology
|
January 31, 2025
Preclinical study and parallel phase II trial evaluating antisense STAT3 oligonucleotide and checkpoint blockade for advanced pancreatic, non-small cell lung cancer and mismatch repair-deficient colorectal cancer
Chad Tang, Genevieve P Hartley, Coline Couillault, et al.
Page
of 9